Author

Arthur Kaser

JAK Inhibition in Practice: Continuing the Story Thread (Pfizer INC)
JAK Inhibition in Practice: Continuing the Story Thread (Pfizer INC)

Arthur Kaser  et al.

FAMIN meets energy metabolism: How purines impact on electrons, protons and autoimmunity
FAMIN meets energy metabolism: How purines impact on electrons, protons and autoimmunity

Arthur Kaser

EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH CROHN’S DISEASE: 104-WEEK EXTENSION RESULTS FROM A PHASE 2 RANDOMIZED CONTROLLED TRIAL
EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH CROHN’S DISEASE: 104-WEEK EXTENSION RESULTS FROM A PHASE 2 RANDOMIZED CONTROLLED TRIAL

Arthur Kaser  et al.

Successful drug development: Academic approach vs industry approach
Successful drug development: Academic approach vs industry approach

Arthur Kaser  et al.

LIPID PEROXIDATION FUELS INTESTINAL INFLAMMATION VIA A TLR2-JNK AXIS
LIPID PEROXIDATION FUELS INTESTINAL INFLAMMATION VIA A TLR2-JNK AXIS

Arthur Kaser  et al.

ER STRESS AS A RHEOSTAT OF LIPID-INDUCED METABOLIC ENTERITIS IN CROHN’S DISEASE
ER STRESS AS A RHEOSTAT OF LIPID-INDUCED METABOLIC ENTERITIS IN CROHN’S DISEASE

Arthur Kaser  et al.

Item 1 - 6 / 6
1